These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 19217709)

  • 1. Role of p53 in the induction of cyclooxygenase-2 by cisplatin or paclitaxel in non-small cell lung cancer cell lines.
    Duarte ML; de Moraes E; Pontes E; Schluckebier L; de Moraes JL; Hainaut P; Ferreira CG
    Cancer Lett; 2009 Jun; 279(1):57-64. PubMed ID: 19217709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cisplatin-induced apoptosis in non-small-cell lung cancer cells is dependent on Bax- and Bak-induction pathway and synergistically activated by BH3-mimetic ABT-263 in p53 wild-type and mutant cells.
    Matsumoto M; Nakajima W; Seike M; Gemma A; Tanaka N
    Biochem Biophys Res Commun; 2016 Apr; 473(2):490-6. PubMed ID: 26996126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TNFAIP8 promotes the proliferation and cisplatin chemoresistance of non-small cell lung cancer through MDM2/p53 pathway.
    Xing Y; Liu Y; Liu T; Meng Q; Lu H; Liu W; Hu J; Li C; Cao M; Yan S; Huang J; Wang T; Cai L
    Cell Commun Signal; 2018 Jul; 16(1):43. PubMed ID: 30064446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promotion of p53 expression and reactive oxidative stress production is involved in zerumbone-induced cisplatin sensitization of non-small cell lung cancer cells.
    Hu Z; Zeng Q; Zhang B; Liu H; Wang W
    Biochimie; 2014 Dec; 107 Pt B():257-62. PubMed ID: 25220870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proanthocyanidins inhibit in vitro and in vivo growth of human non-small cell lung cancer cells by inhibiting the prostaglandin E(2) and prostaglandin E(2) receptors.
    Sharma SD; Meeran SM; Katiyar SK
    Mol Cancer Ther; 2010 Mar; 9(3):569-80. PubMed ID: 20145019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paclitaxel promotes lung cancer cell apoptosis via MEG3-P53 pathway activation.
    Xu J; Su C; Zhao F; Tao J; Hu D; Shi A; Pan J; Zhang Y
    Biochem Biophys Res Commun; 2018 Sep; 504(1):123-128. PubMed ID: 30173893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The MDM2-inhibitor Nutlin-3 synergizes with cisplatin to induce p53 dependent tumor cell apoptosis in non-small cell lung cancer.
    Deben C; Wouters A; Op de Beeck K; van Den Bossche J; Jacobs J; Zwaenepoel K; Peeters M; Van Meerbeeck J; Lardon F; Rolfo C; Deschoolmeester V; Pauwels P
    Oncotarget; 2015 Sep; 6(26):22666-79. PubMed ID: 26125230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cyclin-dependent kinase 2 inhibitor down-regulates interleukin-1beta-mediated induction of cyclooxygenase-2 expression in human lung carcinoma cells.
    Mukhopadhyay P; Ali MA; Nandi A; Carreon P; Choy H; Saha D
    Cancer Res; 2006 Feb; 66(3):1758-66. PubMed ID: 16452236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutant p53 confers chemoresistance in non-small cell lung cancer by upregulating Nrf2.
    Tung MC; Lin PL; Wang YC; He TY; Lee MC; Yeh SD; Chen CY; Lee H
    Oncotarget; 2015 Dec; 6(39):41692-705. PubMed ID: 26497680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of Fas expression and augmentation of Fas/Fas ligand-mediated apoptosis by the synthetic retinoid CD437 in human lung cancer cells.
    Sun SY; Yue P; Hong WK; Lotan R
    Cancer Res; 2000 Nov; 60(22):6537-43. PubMed ID: 11103825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COX-2 potentiates cisplatin resistance of non-small cell lung cancer cells by promoting EMT in an AKT signaling pathway-dependent manner.
    Jiang GB; Fang HY; Tao DY; Chen XP; Cao FL
    Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3838-3846. PubMed ID: 31115011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increasing p53 protein sensitizes non-small cell lung cancer to paclitaxel and cisplatin in vitro.
    Guntur VP; Waldrep JC; Guo JJ; Selting K; Dhand R
    Anticancer Res; 2010 Sep; 30(9):3557-64. PubMed ID: 20944137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silencing of X-linked inhibitor of apoptosis decreases resistance to cisplatin and paclitaxel but not gemcitabine in non-small cell lung cancer.
    Liu Y; Wu X; Sun Y; Chen F
    J Int Med Res; 2011; 39(5):1682-92. PubMed ID: 22117968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulated long non-coding RNA TRPM2-AS inhibits cisplatin resistance of non-small cell lung cancer cells via activation of p53- p66shc pathway.
    Ma LY; Xie XW; Ma L; Pang JL; Xiong XM; Zheng HD; Shen XL; Wen ZG; Wang HY
    Eur Rev Med Pharmacol Sci; 2017 Jun; 21(11):2626-2634. PubMed ID: 28678322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lentivirus-mediated shRNA interference targeting cyclooxygenase-2 inhibits growth of human non-small cell lung cancer.
    Li T; Lu J; Zhong Y
    J BUON; 2013; 18(4):908-14. PubMed ID: 24344016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p38 MAPK-induced MDM2 degradation confers paclitaxel resistance through p53-mediated regulation of EGFR in human lung cancer cells.
    Park SH; Seong MA; Lee HY
    Oncotarget; 2016 Feb; 7(7):8184-99. PubMed ID: 26799187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin-induced chemosensitization to cisplatin depends on P53 status and is inhibited by Jarid1b overexpression in non-small cell lung cancer cells.
    Tortelli TC; Tamura RE; de Souza Junqueira M; da Silva Mororó J; Bustos SO; Natalino RJM; Russell S; Désaubry L; Strauss BE; Chammas R
    Aging (Albany NY); 2021 Sep; 13(18):21914-21940. PubMed ID: 34528900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of Meg3 enhances cisplatin resistance of lung cancer cells through activation of the WNT/β-catenin signaling pathway.
    Xia Y; He Z; Liu B; Wang P; Chen Y
    Mol Med Rep; 2015 Sep; 12(3):4530-4537. PubMed ID: 26059239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal expression pattern of the ASPP family of proteins in human non-small cell lung cancer and regulatory functions on apoptosis through p53 by iASPP.
    Li S; Shi G; Yuan H; Zhou T; Zhang Q; Zhu H; Wang X
    Oncol Rep; 2012 Jul; 28(1):133-40. PubMed ID: 22552744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cisplatin- and paclitaxel-induced apoptosis of ovarian carcinoma cells and the relationship between bax and bak up-regulation and the functional status of p53.
    Jones NA; Turner J; McIlwrath AJ; Brown R; Dive C
    Mol Pharmacol; 1998 May; 53(5):819-26. PubMed ID: 9584207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.